-transparent.png){kind=logo}
Several derivatives of rifamycin SV inhibited ribonucleic acid synthesis and decreased the viability of Histoplasma capsulatum. Both of these effects were enhanced by low concentrations of amphotericin B. The relative potency of the different rifamycin derivatives against H. capsulatum, when used in combination with amphotericin B or alone, was the same as that reported for the inhibition of the reverse transcriptase of ribonucleic acid tumor viruses.
Related Publications
G S Kobayashi, and
S S Cheung, and
D Schlessinger, and
G Medoff
January 1975,
Microbios,
G S Kobayashi, and
S S Cheung, and
D Schlessinger, and
G Medoff
November 1980,
Chest,
G S Kobayashi, and
S S Cheung, and
D Schlessinger, and
G Medoff
April 1990,
Antimicrobial agents and chemotherapy,
G S Kobayashi, and
S S Cheung, and
D Schlessinger, and
G Medoff
January 2003,
Revista cubana de medicina tropical,
G S Kobayashi, and
S S Cheung, and
D Schlessinger, and
G Medoff
April 1987,
Mykosen,
G S Kobayashi, and
S S Cheung, and
D Schlessinger, and
G Medoff
February 1965,
The American journal of the medical sciences,
G S Kobayashi, and
S S Cheung, and
D Schlessinger, and
G Medoff
June 2000,
Antimicrobial agents and chemotherapy,
G S Kobayashi, and
S S Cheung, and
D Schlessinger, and
G Medoff
June 1961,
Antibiotics & chemotherapy (Northfield, Ill.),
G S Kobayashi, and
S S Cheung, and
D Schlessinger, and
G Medoff
November 1977,
Sabouraudia,
G S Kobayashi, and
S S Cheung, and
D Schlessinger, and
G Medoff
May 2014,
Antimicrobial agents and chemotherapy,
